By using dram vial cell culture methods, three commercially available tests for cytomegalovirus (CMV) detection were compared: direct fluorescent monoclonal antibody staining for CMV-specific early and late antigens (direct FA), indirect fluorescent monoclonal antibody staining for a CMV-specific early antigen (indirect FA), and in situ DNA hybridization with a biotinylated CMV-specific DNA probe kit (DNA probe). Of those tests, only the indirect FA provided consistent, reliable virus detection within the initial 24 h postinfection for serial 10-fold dilutions of CMV AD169 (laboratory strain) and for three selected urine samples. However, when used prospectively, the indirect FA failed to detect virus within the initial 10 days postinfection in 15 of 78 consecutive specimens that were eventually positive by cell culture. Although the indirect FA was more sensitive than the direct FA or DNA probe, its utility appeared limited to specimens with high CMV concentrations. On the basis of these data, we recommend that indirect FA be reserved as an adjunct to standard cell culture for selected samples in diagnostic hospital laboratories.
Cytomegalovirus (CMV) is a significant cause of morbidity and mortality among congenitally infected infants and immunocompromised patients (9, 12) . Currently used diagnostic tests for CMV, including serial serologic tests, histopathologic studies for intranuclear inclusions, and tissue culture assays, have been of limited diagnostic utility because they can require several weeks for definitive results. Since antiviral therapy is available for severe CMV infections, rapid detection methods suitable for the clinical laboratory are needed to identify infected patients early so that therapy can be instituted (1, 5) .
The objective of this study was to compare the sensitivity of three commercially available systems for the rapid detection of CMV in a dram vial culture system which is readily adaptable for use in diagnostic clinical laboratories. The three commercially available tests for CMV detection used in this study were direct fluorescent monoclonal antibody staining for CMV-specific early and late antigens (direct FA; Whittaker M. A. Bioproducts, Walkersville, Md.), indirect fluorescent monoclonal antibody staining for a CMV-specific early nuclear antigen (indirect FA; New England Nuclear Corp., Beverly, Ma.), and in situ DNA hybridization with a biotinylated DNA probe (Enzo Biochemicals, New York, N.Y.). Their sensitivity was determined by testing a laboratory CMV strain (AD169) at serial 10-fold dilutions, and their applicability for rapid detection of clinical CMV strains was tested by screening multiple clinical specimens. The (8) . The virus was diluted serially with supplemented minimum essential medium with 5% fetal bovine serum, 100 U of penicillin per ml, 100 ,ug of streptomycin per ml, and 100 mg of amphotericin B per ml (supplemented MEM) to produce multiplicities of infection (MOI) of 0.1, 1.0, and 10 infectious particles per cell. For the prospective study of clinical samples, random throat, urine, sputum, and bronchoalveolar lavage specimens were inoculated into transport medium and either inoculated into cell cultures or dram vials immediately or frozen at -70°C for later study. Urine specimens were diluted with gelatin-Tris-Hanks balanced salts solution, treated with 2.0 ml of 70% sorbitol, and alkalinized to pH 7.0 to 7.4 with 7.5% sodium bicarbonate before inoculation of cell culture or freezing. Frozen specimens were thawed at 37°C and diluted at 1:10 with supplemented MEM before viral culture. detecting CMV in clinical samples, three urine samples known to be positive by tissue culture assay were inoculated into dram vials and analyzed. Table 2 illustrates the results of testing three urine specimens for clinical CMV strains compared with standard CPE. For specimen a, indirect FA staining was detected at 1 day (17 h) p.i., direct FA was detected at 3 days (65 h) p.i., and CPE was detected at 6 days (144 h) p.i. For specimen b, indirect FA was noted at 1 day (22 h) p.i., DNA hybridization was noted at 3 days (72 h) p.i., and CPE was detected at 7 days (168 h) p.i. Specimen c had positive direct and indirect FA staining at 1 day (16 h) p.i., with DNA hybridization and CPE appearing at 2 days (45 h) p.i. The difficulties described above with early direct FA staining (<4 days p.i.) and late hybridized complex color visualization (>6 days p.i.) were also encountered in evaluating the clinical specimens. No averse interactions were noted in visualizing the hybridized complexes when the DNA probe was applied after FA staining reagents had been applied to the cell monolayers. There were no detectable CMV-specific early antigens or hybridized DNA complexes immediately after dram vial inoculation and centrifugation (time point zero) with the three assays. This was a consistent finding among the CMV AD169 and clinical urine specimens tested. These results indicate that the indirect FA technique utilizing a monoclonal antibody to an early nuclear antigen of CMV is a useful procedure for detecting CMV in clinical specimens that have a significant amount of infectious virus.
We next attempted to assess the usefulness of the indirect FA technique for detecting CMV in routine clinical samples submitted to our clinical microbiology laboratory. In a prospective, blinded study of 78 consecutive clinical samples submitted for CMV culture, 15 were positive for CMV. They required an average of 12.2 days to appearance of CPE. None of the 78 samples had positive indirect FA staining after 10 days p.i., including those that subsequently developed CPE on culture. These results indicate that the indirect FA may not be useful for routine clinical work.
DISCUSSION
Numerous rapid detection methods have been described in which monoclonal antibodies or DNA probes are used to screen clinical specimens for CMV (2-4, 6, 7, 11, 13, 14, 16-18) . In this comparative study of three commercially available tests, indirect FA staining for a CMV-specific early antigen was the most rapid and reliable modality for detecting CMV AD169 in a dram vial cell culture system. However, when applied to clinical specimens, it was most efficacious only for evaluating those with high virus concentrations.
Characteristic CPE in tube cell culture has been considered the standard test for CMV detection (12) , although it may not appear for up to 8 weeks p.i. Recent studies have utilized dram (shell) vials containing MRC-5 cell monolayers with specimens centrifuged onto the monolayer to enhance viral adsorption and infection (6, 7, 17) . Excellent viral recovery compared with that in tube culture has been noted with that method (6, 7, 13, 17) .
In (2, 3, 10, 11, 16, 18) . However, there have been no previous publications describing the application of DNA probe techniques to dram vial cell culture systems. In situ DNA hybridization assays were performed successfully in this study with dram vial cell monolayers, and no antagonistic interactions were evident when FA staining and DNA probe testing were performed sequentially on the same monolayers. Although good sensitivity has been reported with the biotinylated DNA probes, hybridized DNA complexes were not detected for long time periods after early nuclear antigens were detectable with the FA stains (2, 10, 11). Among the clinical urine specimens, the earliest time that CMV DNA was noted was at 45 h p.i. with the probe kit compared with early antigen detection at 16 h p.i. with the FA stains.
Since neither CMV early antigens nor DNA was noted at time point zero, it is likely that sufficient time periods are necessary for adequate early antigen and DNA production to occur before a positive test result is generated. The longer time interval required for hybridized DNA complex detection is likely related to the sequential events of the CMV replicative cycle, in which early proteins are synthesized before the initiation of viral DNA replication (12) . Active CMV protein production and DNA replication appear crucial for successful application of the tests evaluated in this study. Their suitability for detecting latent virus remains uncertain.
The limitations of indirect FA staining for rapid CMV detection are illustrated through the prospective evaluation of clinical specimens. Positive indirect FA was noted only for the three selected urine samples with rapid time to development of CPE in tube culture (<7 days p.i.), indicating relatively high virus concentrations. It offered no advantage to tube culture for CMV detection when blinded, random specimens having widely varied virus concentrations were screened (average time to CPE development, 12.2 days). It is possible that freeze-thawing of some specimens followed by 1:10 dilution may have altered the infectivity of any CMV present. Thus, although it is adaptable for use in hospital laboratories, the indirect FA test does not appear to have sufficient sensitivity at low virus concentrations to be relied upon in place of standard tube cell culture for CMV detection.
In summary, there are two principal conclusions from this investigation. First, indirect FA provides better results than VOL. 26, 1988 on August 27, 2017 by guest http://jcm.asm.org/ direct FA or DNA probe for rapid CMV detection. It is suitable for the dram vial cell culture system and is reliable for clinical samples with high virus concentrations. Second, in the routine hospital laboratory, the indirect FA test is not significantly better than standard tissue culture alone for detecting CMV. When applied to specimens with unpredictable viral concentrations, it is best considered an adjunctive procedure to screen for samples with high virus concentrations. Unless the population under study has a propensity for high CMV excretion, it may be more useful for detecting viruses with more rapid replicative cycles, such as herpes simplex and influenza viruses. The FA technique, either direct or indirect, is still very useful for culture confirmation.
